A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis. - Yuan XL; Zhao YP; Huang J; Liu JC; Mao WQ; Yin J; Peng BW; Liu WH; Han S; He XH (CNS neuroscience & therapeutics, 2018)